Intralipid (Baxter Healthcare CORP)


Welcome to the PulseAid listing for the Intralipid drug offered from Baxter Healthcare CORP. This Lipid Emulsion [EPC],Lipids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare CORP
NON-PROPRIETARY NAME: SOYBEAN OIL
SUBSTANCE NAME: SOYBEAN OIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lipid Emulsion [EPC],Lipids [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: EMULSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-12-12
END MARKETING DATE: 0000-00-00


Intralipid HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIntralipid from Baxter Healthcare CORP
LABELER NAME: Baxter Healthcare CORP
DEA SCHEDULE:
ACTIVE STRENGTH: 10(g/100mL)
START MARKETING DATE: 2014-12-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-0518_ff58d256-c2af-459a-93cd-f8e88e935653
PRODUCT NDC: 0338-0518
APPLICATION NUMBER: NDA017643

Other SOYBEAN OIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AMI Cosmetic Co.,Ltd.essenHERB Soybean 90 Deep Cleansing
B. Braun Medical Inc.NutriLipid I.V. Fat Emulsion
Baxter Healthcare CORPIntralipid
Baxter Healthcare CorporationIntralipid